Ann Neurol
- MARGONI M, Pagani E, Meani A, Preziosa P, et al
Cognitive Impairment Is Related to Glymphatic System Dysfunction in Pediatric
Multiple Sclerosis.
Ann Neurol. 2024 Mar 13. doi: 10.1002/ana.26911.
Diabet Med
- EMBICK R, Jackson M, Stewart R
The impact of stigma on the management of type 1 diabetes: A systematic review.
Diabet Med. 2024 Feb 15:e15299. doi: 10.1111/dme.15299.
- HARROD JC, Cheung YM, Buckley L, Cromwell GE, et al
Impact of personalized diabetes care on distress and treatment satisfaction in
people with breast cancer.
Diabet Med. 2024 Jan 30:e15292. doi: 10.1111/dme.15292.
- ZAREMBA N, Harrison A, Brown J, Allan J, et al
Protocol for the STEADY intervention for type 1 diabetes and disordered eating:
Safe management of people with Type 1 diabetes and EAting Disorders studY.
Diabet Med. 2024 Jan 8:e15273. doi: 10.1111/dme.15273.
- JONES CJ, Read R, O'Donnell N, Wakelin K, et al
PRIORITY Trial: Results from a feasibility randomised controlled trial of a
psychoeducational intervention for parents to prevent disordered eating in
children and young people with type 1 diabetes.
Diabet Med. 2023 Dec 15:e15263. doi: 10.1111/dme.15263.
- KUBILAY E, Trawley S, Ward GM, Fourlanos S, et al
Real-world lived experience of older adults with type 1 diabetes after an
automated insulin delivery trial.
Diabet Med. 2023 Dec 10:e15264. doi: 10.1111/dme.15264.
- HARRINGTON MP, Satherley RM, John M, O'Donnell N, et al
Reliability and validity of a parent-reported screening tool for disordered
eating in children and young people with Type 1 diabetes.
Diabet Med. 2023 Nov 4:e15256. doi: 10.1111/dme.15256.
J Autoimmun
- HUANG W, Jin T, Zheng W, Yin Q, et al
Identifying the genetic association between systemic lupus erythematosus and the
risk of autoimmune liver diseases.
J Autoimmun. 2024;145:103188.
J Neuroimmunol
- KORAL G, Ulusoy C, Cossins J, Lazaridis K, et al
Silencing of FCRLB by shRNA ameliorates MuSK-induced EAMG in mice.
J Neuroimmunol. 2023;383:578195.
- FOGEL A, Olcer M, Goel A, Feng X, et al
Novel biomarkers and interferon signature in secondary progressive multiple
sclerosis.
J Neuroimmunol. 2024;389:578328.
J Neurol
- VILASECA A, Farina A, Villagran-Garcia M, Pegat A, et al
Neurological autoimmunity in melanoma patients: a comparison between those
exposed and non-exposed to immune checkpoint inhibitors.
J Neurol. 2024 Mar 11. doi: 10.1007/s00415-024-12252.
Mult Scler
- EHLING R, Seebacher B, Brenneis C
Letter to the editor: Mobile health interventions in multiple sclerosis: A
systematic review.
Mult Scler. 2024 Mar 11:13524585241234789. doi: 10.1177/13524585241234789.
- NAKAMURA K, Sun Z, Hara-Cleaver C, Bodhinathan K, et al
Natalizumab reduces loss of gray matter and thalamic volume in patients with
relapsing-remitting multiple sclerosis: A post hoc analysis from the randomized,
placebo-controlled AFFIRM trial.
Mult Scler. 2024 Mar 12:13524585241235055. doi: 10.1177/13524585241235055.
- JOHNSSON M, Stenberg YT, Farman HH, Blennow K, et al
Serum neurofilament light for detecting disease activity in individual patients
in multiple sclerosis: A 48-week prospective single-center study.
Mult Scler. 2024 Mar 13:13524585241237388. doi: 10.1177/13524585241237388.
- ROCCHI C, Forcadela M, Kelly P, Linaker S, et al
The absence of antibodies in longitudinally extensive transverse myelitis may
predict a more favourable prognosis.
Mult Scler. 2024;30:345-356.
- KUBICKI K, Stefoski D
Iatrogenic myelodysplastic syndrome complicating multiple sclerosis: A case
report.
Mult Scler. 2024 Mar 8:13524585241235539. doi: 10.1177/13524585241235539.
N Engl J Med
- DRIVENES JL, Bygum A
Spontaneous Oral Purpura in Immune Thrombocytopenia.
N Engl J Med. 2024;390:1029.
Neurologia (Engl Ed)
- TREJO-GABRIEL-GALAN JM
Euthanasia and assisted suicide in neurological diseases: a systematic review.
Neurologia (Engl Ed). 2024;39:170-177.
- JIMENEZ-MORALES RM, Broche-Perez Y, Macias-Delgado Y, Sebrango C, et al
Cognitive rehabilitation program in patients with multiple sclerosis: A pilot
study.
Neurologia (Engl Ed). 2024;39:135-146.
Neurology
- THAKOLWIBOON S, Dubey D
Redefining Patient Evaluation in Anti-IgLON5 Disease: Anti-IgLON5 Disease
Composite Score.
Neurology. 2024;102:e209213.
- GAIG C, Gruter T, Heidbreder A, Sabater L, et al
Development of a Composite Score for the Clinical Assessment of Anti-IgLON5
Disease.
Neurology. 2024;102:e208101.
- KOTHAPALLI NP, Chompoopong P, McKeon A, Dubey D, et al
Teaching Video NeuroImage: Adaptor-Related Protein-Complex-3 Subunit beta-2
Immunoglobulin-G-Associated Autoimmune Ataxia.
Neurology. 2024;102:e209257.
PLoS One
- FLOYD L, Dhaygude A, Mitra S, Rowland C, et al
Developing a disease-specific patient reported outcome measure to enhance
understanding of the lived experiences of ANCA associated vasculitis: A protocol
paper.
PLoS One. 2024;19:e0298796.
Proc Natl Acad Sci U S A
- VENEGAS-SOLIS F, Staliunaite L, Rudolph E, Munch CC, et al
A type I interferon regulatory network for human plasmacytoid dendritic cells
based on heparin, membrane-bound and soluble BDCA-2.
Proc Natl Acad Sci U S A. 2024;121:e2312404121.
Semin Hematol
- WANG SS
Epidemiology and etiology of diffuse large B-cell lymphoma.
Semin Hematol. 2023;60:255-266.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016